Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: long-gone who wrote (62038)	12/16/2000 11:37:33 AM
From: long-gone	Respond to of 116779

Look at this & the name all, yes, the email foold me at first too: Dear Investor, There's gold in human DNA. Now that Craig Venter has made the map, the race is on to find the genes hidden within. Find the gene and patent the drug... Patent the drug and count the money! No wonder Business Week recently declared a "genome gold rush." But what you haven't been told is how private investors will make money in this bonanza...and that is why I'm writing to you today. You see, many investors, excited by this breakthrough, are piling in...buying things they don't understand...trading on wild rumors.and losing their shirts. But that's not going to happen to you. My name is Mike Murphy, and I've been investing in biotech since artificial Interluken II changed the world and a little company called Amgen had its IPO. I've made a lot of investors rich in biotech, but I've never seen an opportunity like this before. There are two biotech stocks that we will buy immediately. One is the company that will soon dominate the field in the way that Microsoft dominates computers today. Yet it didn't even exist some months ago. Buy 100 shares at the price designated. Expect a ten-bagger. Details in my new special report "The Great Genome Gold Rush," yours free when you click here: ppi-orders.com The second company may make my first pick look like a slowpoke. WARNING: Don't invest in this second company unless you can afford to lose EVERYTHING! That said, if this takes off, it will rival the ride some of us took on Qualcomm last year. You see, if the human genome is a modern day Gold Rush, the cure for cancer is the Mother Lode! There is no bigger payoff! One tiny company is way ahead of the pack in tracking down mutating cells and "resetting" them. In effect, the cells turn on the cancer and kill it. This company is in the final stages of testing. A group of very lucky people are recovering miraculously from metastic melanoma. And I happen to know that the FDA is ready to give the therapy extremely rapid review. Buy 50 shares at the price designated. Expect a 1,000- percenter-or zero. Details in "The Great Genome Gold Rush," yours free when you click here: ppi-orders.com Thought for today. The biotech revolution gives us freedom from things we dread. Alzheimer's. Diabetes. Cancer. And, perhaps one day, death itself. It also gives you, as an investor, an opportunity for extraordinary wealth. Cup your hands beneath this waterfall, and drink. Until next time, Mike Murphy Biotech Investing P.S. Respond now and receive "The Great Genome Gold Rush" free. This offer is for a very limited time, so click here now: